Shandong Xinhua Pharmaceutical Company Limited (stock code: 00719) has notified investors that its board of directors will convene at 9:00 a.m. on Friday, 27 March 2026, in the Company’s conference room at No. 1 Lutai Avenue, Hi-tech District, Zibo, Shandong, China.

The agenda comprises three items:

1. Approval of the audited consolidated results for the financial year ended 31 December 2025.

2. Consideration of a final dividend recommendation.

3. Discussion of any other business matters.

The meeting will be chaired by Mr. He Tongqing, with executive directors Mr. He Tongqing, Mr. Xu Wenhui and Mr. Hou Ning, four independent non-executive directors and two non-executive directors in attendance, as listed in the announcement.

The company released the notice on 13 March 2026. Investors should monitor subsequent disclosures for the finalised FY 2025 financial statements and any dividend decision.